Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients.
17 May 2025 (08:00 - 12:45)
Organised by: 

About the speaker

Tectonic Therapeutic, Inc., Watertown (United States of America)
6 More presentations in this session
Professor S. Greene (Durham, US)
Doctor A. Porcari (London, GB)
Professor I. Olivotto (Florence, IT)
Doctor J. Nunez Villota (Valencia, ES)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025


